IBD's list of the 50 Most Sustainable Companies for 2025 combines high sustainability scores and superior stock ratings. Would these be a good fit for your portfolio?

Hims stock surged Wednesday, topping a buy point, after the telehealth behemoth announced a menopause care program.

Innovator IBD 50 ETF (FFTY) is outperforming major indexes in 2024. See here for an analysis of its risks, and whether this ...

Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...

US clinical-stage biotech Spyre Therapeutics on Wednesday announced the closing of its previously announced underwritten public offering of 17,094,594 shares of its common stock, including the full ...

The rate of Americans diagnosed with digestive disorders and gastrointestinal cancers is rising, especially in those ages 50 ...

Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

When Phyllis Burk was diagnosed with Crohn’s disease nearly 50 years ago, it wasn’t as simple as looking up information ...

Diwali's festive glow masks a growing concern: colorectal cancer is increasingly striking young adults, a trend alarming ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Depression may raise the risk for inflammatory conditions; the risk for Parkinson's disease persists after adjusting for ...

Cerulli research sees major acquisitions and mergers drive growth in the IBD channel, with advisors increasingly drawn to ...